George Sellers
Stock Analyst at Stephens & Co.
(0.65)
# 3,729
Out of 4,711 analysts
57
Total ratings
21.74%
Success rate
-25.38%
Average return
Main Sectors:
Stocks Rated by George Sellers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CUTR Cutera | Maintains: Overweight | $10 → $5 | $0.36 | +1,274.76% | 11 | Aug 9, 2024 | |
| ESTA Establishment Labs Holdings | Reiterates: Overweight | $68 | $40.01 | +69.96% | 7 | Aug 7, 2024 | |
| TFX Teleflex | Maintains: Overweight | $275 → $290 | $178.16 | +62.78% | 9 | Aug 2, 2024 | |
| VCEL Vericel | Maintains: Overweight | $56 → $58 | $56.50 | +2.65% | 2 | Aug 2, 2024 | |
| TMDX TransMedics Group | Maintains: Overweight | $151 → $178 | $61.70 | +188.49% | 2 | Aug 2, 2024 | |
| ANIK Anika Therapeutics | Reiterates: Equal-Weight | $24 | $16.31 | +47.15% | 6 | May 29, 2024 | |
| FNA Paragon 28 | Reiterates: Overweight | $18 | $10.03 | +79.46% | 3 | Apr 5, 2024 | |
| ENOV Enovis | Initiates: Overweight | $72 | $43.12 | +66.98% | 1 | Feb 13, 2024 | |
| APYX Apyx Medical | Maintains: Overweight | $8 → $5 | $1.57 | +218.47% | 2 | Nov 10, 2023 | |
| TMCI Treace Medical Concepts | Reiterates: Equal-Weight | $25 | $6.96 | +259.20% | 4 | Sep 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $57 | $24.82 | +129.65% | 6 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $71 | $150.88 | -52.94% | 4 | May 8, 2023 |
Cutera
Aug 9, 2024
Maintains: Overweight
Price Target: $10 → $5
Current: $0.36
Upside: +1,274.76%
Establishment Labs Holdings
Aug 7, 2024
Reiterates: Overweight
Price Target: $68
Current: $40.01
Upside: +69.96%
Teleflex
Aug 2, 2024
Maintains: Overweight
Price Target: $275 → $290
Current: $178.16
Upside: +62.78%
Vericel
Aug 2, 2024
Maintains: Overweight
Price Target: $56 → $58
Current: $56.50
Upside: +2.65%
TransMedics Group
Aug 2, 2024
Maintains: Overweight
Price Target: $151 → $178
Current: $61.70
Upside: +188.49%
Anika Therapeutics
May 29, 2024
Reiterates: Equal-Weight
Price Target: $24
Current: $16.31
Upside: +47.15%
Paragon 28
Apr 5, 2024
Reiterates: Overweight
Price Target: $18
Current: $10.03
Upside: +79.46%
Enovis
Feb 13, 2024
Initiates: Overweight
Price Target: $72
Current: $43.12
Upside: +66.98%
Apyx Medical
Nov 10, 2023
Maintains: Overweight
Price Target: $8 → $5
Current: $1.57
Upside: +218.47%
Treace Medical Concepts
Sep 12, 2023
Reiterates: Equal-Weight
Price Target: $25
Current: $6.96
Upside: +259.20%
Aug 14, 2023
Reiterates: Overweight
Price Target: $57
Current: $24.82
Upside: +129.65%
May 8, 2023
Reiterates: Overweight
Price Target: $71
Current: $150.88
Upside: -52.94%